Cancer Family
Respiratory System Neoplasm
CI-CAN-00000049Explore in graph →
Non-malignant2,727 active trials51 approved drugs619 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000049Explore in graph →
Clinical trials
11,614 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00531180 | 4-Dimensional CT Derived Ventilation Versus SPECT Aerosol Ventilation in Patients With Thoracic Malignancies | completed | Phase 2 | 31 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 25, 2018 | clinicaltrials |
| NCT00363766 | Study of LY573636-Sodium in Patients With Metastatic Non-Small Cell Lung Cancer | completed | Phase 2 | 52 | Eli Lilly and CompanyINDUSTRY | 2 | Oct 19, 2018 | clinicaltrials |
| NCT00896454 |
| Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium |
| completed |
| Phase 2 |
| 33 |
| AmgenINDUSTRY |
| 5 |
| Oct 17, 2018 |
| clinicaltrials |
| NCT00864721 | Sunitinib Non Small Cell Lung Cancer Patients Over 70 | completed | Phase 2 | 63 | US Oncology ResearchINDUSTRY | 1 | Oct 16, 2018 | clinicaltrials |
| NCT02875340 | A Study of VAL401 in the Treatment of Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer | completed | Phase 2 | 8 | ValiSeek LimitedINDUSTRY | 0 | Oct 15, 2018 | clinicaltrials |
| NCT00580398 | Smoking Cessation Intervention for Thoracic Patients | completed | Phase 1 / Phase 2 | 49 | Massachusetts General HospitalOTHER | 1 | Oct 12, 2018 | clinicaltrials |
| NCT00188279 | Minimum Dose Computed Tomography of the Thorax for Follow-up in Patients With Resected Lung Carcinoma | completed | Phase 2 | 311 | University Health Network, TorontoOTHER | 1 | Oct 11, 2018 | clinicaltrials |
| NCT00520702 | 3-Dimensional Conformal Radiation Therapy Versus Intensity Modulated Radiation Therapy | completed | Phase 2 | 168 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 5, 2018 | clinicaltrials |
| NCT00994097 | NGR-hTNF in Combination With Standard Chemotherapy to Treat Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 121 | AGC Biologics S.p.A.INDUSTRY | 1 | Sep 27, 2018 | clinicaltrials |
| NCT00252382 | Safety and Efficacy Clinical Study of SNS-595 for Second-Line Therapy in Patients With Advanced NSCLC | completed | Phase 2 | 31 | Sunesis PharmaceuticalsINDUSTRY | 1 | Sep 24, 2018 | clinicaltrials |
| NCT02334007 | Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery | completed | Phase 1 / Phase 2 | 102 | McMaster UniversityOTHER | 1 | Sep 18, 2018 | clinicaltrials |
| NCT01174563 | A Study on the Correlation Between Tarceva (Erlotinib) - Induced Rash and Efficacy in EGFR Mutated Participants With Advanced Non-Small Cell Lung Cancer Receiving First-Line Therapy | completed | Phase 2 | 60 | Hoffmann-La RocheINDUSTRY | 1 | Sep 17, 2018 | clinicaltrials |
| NCT01310036 | A Study of Tarceva (Erlotinib) as First Line Therapy in Participants With Non-Small Cell Lung Cancer Harbouring Epidermal Growth Factor Receptor (EGFR) Mutations | completed | Phase 2 | 208 | Hoffmann-La RocheINDUSTRY | 4 | Sep 12, 2018 | clinicaltrials |
| NCT00638937 | AZD0530 to Treat Recurrent Stage IIIB/IV NSCLC Previously Treated With Combination Chemotherapy | completed | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | Aug 29, 2018 | clinicaltrials |
| NCT02123849 | Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current Smokers | completed | Phase 2 | 54 | National Cancer Institute (NCI)NIH | 1 | Aug 29, 2018 | clinicaltrials |
| NCT01871805 | A Study of Alectinib (CH5424802/RO5424802) in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 1 / Phase 2 | 134 | Hoffmann-La RocheINDUSTRY | 2 | Aug 21, 2018 | clinicaltrials |
| NCT01207063 | Adaptive Radiotherapy in Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 40 | Maastricht Radiation OncologyOTHER | 1 | Aug 17, 2018 | clinicaltrials |
| NCT00003202 | Gemcitabine Plus Radiation Therapy or Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 40 | Wake Forest University Health SciencesOTHER | 1 | Aug 10, 2018 | clinicaltrials |
| NCT01443078 | Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN) | completed | Phase 2 | 42 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 9, 2018 | clinicaltrials |
| NCT01901653 | Rovalpituzumab Tesirine (SC16LD6.5) in Recurrent Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 82 | StemcentrxINDUSTRY | 1 | Aug 9, 2018 | clinicaltrials |
| NCT00654420 | A Study Evaluating Dalotuzumab (MK-0646) in Combination With Erlotinib for Participants With Non-Small Cell Lung Cancer (MK-0646-007) | completed | Phase 2 | 95 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Aug 8, 2018 | clinicaltrials |
| NCT00298896 | Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer | completed | Phase 2 | 55 | Sunesis PharmaceuticalsINDUSTRY | 2 | Jul 26, 2018 | clinicaltrials |
| NCT00098956 | 7-hydroxystaurosporine and Topotecan Hydrochloride in Treating Patients With Relapsed or Progressed Small Cell Lung Cancer | completed | Phase 2 | 19 | National Cancer Institute (NCI)NIH | 1 | Jul 23, 2018 | clinicaltrials |
| NCT00527735 | Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC) | completed | Phase 2 | 334 | Bristol-Myers SquibbINDUSTRY | 8 | Jul 18, 2018 | clinicaltrials |
| NCT01922583 | AUY922 in Patient With Stage IV NSCLC(NSCLC) | completed | Phase 2 | 31 | National Taiwan University HospitalOTHER | 1 | Jul 18, 2018 | clinicaltrials |
| NCT02005458 | Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy | completed | Phase 2 | 80 | Xiamen Amoytop Biotech Co., Ltd.INDUSTRY | 1 | Jul 17, 2018 | clinicaltrials |
| NCT02025114 | Selumetinib in Combination With Gefitinib in NSCLC Patients | completed | Phase 1 / Phase 2 | 34 | National Taiwan University HospitalOTHER | 1 | Jul 10, 2018 | clinicaltrials |
| NCT01553916 | Neuroprotective Effects of Lithium in Patients With Small Cell Lung Cancer Undergoing Radiation Therapy to the Brain | completed | Phase 1 / Phase 2 | 19 | Washington University School of MedicineOTHER | 1 | Jul 5, 2018 | clinicaltrials |
| NCT01827267 | Neratinib With and Without Temsirolimus for Patients With HER2 Activating Mutations in Non-Small Cell Lung Cancer | completed | Phase 2 | 62 | Puma Biotechnology, Inc.INDUSTRY | 2 | Jul 3, 2018 | clinicaltrials |
| NCT01557959 | Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | 45 | Wake Forest University Health SciencesOTHER | 1 | Jun 29, 2018 | clinicaltrials |
| NCT01234038 | Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Carboplatin and Paclitaxel(NSCLC) | completed | Phase 1 / Phase 2 | 116 | Ionis Pharmaceuticals, Inc.INDUSTRY | 4 | Jun 27, 2018 | clinicaltrials |
| NCT00890825 | AZD6244 in Combination With Docetaxel Versus Docetaxel Alone in KRAS Mutation Positive NSCLC Patients | completed | Phase 2 | 88 | AstraZenecaINDUSTRY | 12 | Jun 20, 2018 | clinicaltrials |
| NCT01864681 | Combination of Metformin With Gefitinib to Treat NSCLC(CGMT) | completed | Phase 2 | 224 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityOTHER | 1 | Jun 20, 2018 | clinicaltrials |
| NCT01829113 | Phase II Trial of Carboplatin and Pemetrexed +/- OGX-427 in Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer(Spruce) | completed | Phase 2 | 155 | SCRI Development Innovations, LLCOTHER | 1 | Jun 8, 2018 | clinicaltrials |
| NCT00445198 | A Phase 1/2a Study of ABT-263 in Subjects With Small Cell Lung Cancer (SCLC) or Other Non-Hematological Malignancies | completed | Phase 1 / Phase 2 | 86 | AbbVie (prior sponsor, Abbott)INDUSTRY | 3 | Jun 6, 2018 | clinicaltrials |
| NCT00870870 | A Study of IMC-A12 (Cixutumumab) With and Without Other Standard Chemotherapies in Participants With Lung Cancer Who Have Not Received Chemotherapy Before | completed | Phase 2 | 64 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 1, 2018 | clinicaltrials |
| NCT00687297 | Study of Vandetanib Combined With Chemotherapy to Treat Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 162 | PrECOG, LLC.OTHER | 1 | May 30, 2018 | clinicaltrials |
| NCT02979821 | Poziotinib in Stage IV Lung Adenocarcinoma With HER2 Mutation (KASTT001) | completed | Phase 2 | 6 | Korean Association for the Study of Targeted TherapyOTHER | 1 | May 24, 2018 | clinicaltrials |
| NCT01139775 | A Study in Non Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 76 | Eli Lilly and CompanyINDUSTRY | 2 | May 18, 2018 | clinicaltrials |
| NCT01204099 | Study of PX-866 and Docetaxel in Solid Tumors | completed | Phase 1 / Phase 2 | 223 | Cascadian Therapeutics Inc.INDUSTRY | 2 | May 16, 2018 | clinicaltrials |
| NCT01029678 | Concomitant Radio-chemotherapy in the Elderly(RACCOSA) | completed | Phase 2 | 48 | University Hospital, LimogesOTHER | 1 | May 3, 2018 | clinicaltrials |
| NCT00078390 | Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 9 | ShionogiINDUSTRY | 1 | May 2, 2018 | clinicaltrials |
| NCT01588145 | Phase I/II Trial to Evaluate Safety, Tolerability and Pharmacokinetic Profile of HM61713 in NSCLC Patients | completed | Phase 1 / Phase 2 | 273 | Hanmi Pharmaceutical Company LimitedINDUSTRY | 1 | Apr 24, 2018 | clinicaltrials |
| NCT02444819 | Phase II Trial to Evaluate the Efficacy and Safety of HM61713 as the 1st-line NSCLC Anticancer Therapy | completed | Phase 2 | 33 | Hanmi Pharmaceutical Company LimitedINDUSTRY | 1 | Apr 24, 2018 | clinicaltrials |
| NCT02284139 | Pilot Trial of EGF Ointment for the Patients With EGFR-i Related Skin Side Effects | completed | Phase 2 / Phase 3 | 90 | Dong-A University HospitalOTHER | 1 | Apr 23, 2018 | clinicaltrials |
| NCT00266877 | Study Evaluating the Safety Of HKI-272 (Neratinib) In Subjects With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 172 | Puma Biotechnology, Inc.INDUSTRY | 5 | Apr 13, 2018 | clinicaltrials |
| NCT00410904 | AZD2171 and Pemetrexed Disodium in Treating Patients With Relapsed Non-Small Cell Lung Cancer | completed | Phase 2 | 60 | National Cancer Institute (NCI)NIH | 1 | Apr 13, 2018 | clinicaltrials |
| NCT01854034 | Phase 2 Study of AUY922 in NSCLC Patients With Exon 20 Insertion Mutations in EGFR | completed | Phase 2 | 29 | Massachusetts General HospitalOTHER | 1 | Apr 10, 2018 | clinicaltrials |
| NCT00654030 | Allogeneic Cellular Vaccine 1650-G for Non-Small Cell Lung Cancer | completed | Phase 2 | 12 | Edward HirschowitzOTHER | 1 | Apr 9, 2018 | clinicaltrials |
| NCT00111839 | Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer | completed | Phase 2 | 150 | EMD SeronoINDUSTRY | 3 | Apr 6, 2018 | clinicaltrials |
Data updated 24 days agoSource updated Oct 25, 2018source: clinicaltrials